top of page
A L T I T U D E
Life Science Ventures
HOME
ABOUT
PORTFOLIO
Fund IV
Fund III
Fund II
Historical
TEAM
NEWS
CONTACT
More
Use tab to navigate through the menu items.
Companies in the News
Apr 19, 2022
Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform
SOMERVILLE, Mass.--(BUSINESS WIRE)--Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known...
Apr 12, 2022
Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing
Ansa’s next-generation enzymatic DNA synthesis technology will dramatically accelerate innovation across every industry enabled by...
bottom of page
